Antibody-directed enzyme prodrug therapy (Adept)
- 1 January 1994
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 28 (1-3) , 187-193
- https://doi.org/10.1016/0168-3659(94)90165-1
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compoundsEuropean Journal of Cancer and Clinical Oncology, 1991
- Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localisation in a xenograft modelBritish Journal of Cancer, 1990
- The First Bagshawe lecture: Towards generating cytotoxic agents at cancer sitesBritish Journal of Cancer, 1989
- A cytotoxic agent can be generated selectively at cancer sitesBritish Journal of Cancer, 1988
- Repeated antitumour antibody therapy in man with suppression of the host response by cyclosporin ABritish Journal of Cancer, 1988
- Cyclosporin A prevents the anti-murine antibody response to a monoclonal anti-tumour antibody in rabbitsBritish Journal of Cancer, 1988
- Antibody directed enzymes revive anti-cancer prodrugs conceptBritish Journal of Cancer, 1987
- Carbohydrate-mediated clearance of immune complexes from the circulation. A role for galactose residues in the hepatic uptake of IgG-antigen complexes.Published by Elsevier ,1980